Stabilisation of Recombinant Human Basic Fibroblast Growth Factor (FGF-2) against Stressors Encountered in Medicinal Product Processing and Evaluation
Basic fibroblast growth factor (FGF-2) is a highly labile protein with strong potential for tissue engineering. The aim of this study was to develop FGF-2 formulations that are stable against physical stressors encountered in pharmaceutical processing and evaluation. Pharmaceutical excipients, alone...
Guardado en:
Autores principales: | Leah R. Benington, Gunesh Rajan, Cornelia Locher, Lee Yong Lim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a9be62efdaa34c7ea37779854c6c3095 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum intact fibroblast growth factor 23 in healthy paediatric population
por: Stanczyk Malgorzata, et al.
Publicado: (2021) -
Stimulation of wound healing using bioinspired hydrogels with basic fibroblast growth factor (bFGF)
por: Zhang X, et al.
Publicado: (2018) -
Morphometric analysis of the growth factors influence on fibroblastic phase of inflammation at experimental myocardial infraction
por: M. G. Shurygin, et al.
Publicado: (2014) -
The association between fibroblast growth factor receptor 1 gene amplification and lung cancer: a meta-analysis
por: Jian-Long Miao, et al.
Publicado: (2019) -
Mutaciones del gen del receptor 3 del Factor de Crecimiento de Fibroblasto (FGFR3) en pacientes chilenos con talla baja idiopática, hipocondroplasia y acondroplasia
por: Mancilla V,Edna E, et al.
Publicado: (2003)